Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX)

CUSIP: 34962G109

Q4 2020 13F Holders as of 31 Dec 2020

Holder snapshot 6 signals
Share change
+1,580,559
SEC-reported price per share
$36.41
Number of holders
49
Value change
+$56,276,590
Number of buys
33
Number of sells
19
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
20,563,488

Security key

34962G109

Report period

Q4 2020

Institutions

49

Top holders

10

Ownership snapshot

Top reported holders of FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ArrowMark Colorado Holdin...
Disclosed value leader
ArrowMark Colorado Holdin...
Comparable rows
15/15
Latest evidence
30 Sep 2020
13F Lead comparable stake: 14% Showing 1-6 of 15 holder rows.

Quick read

ArrowMark Colorado Holdings LLC leads the comparable SEC ownership view at 14%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ArrowMark Colorado Holdings LLC's linked filing trail.
Comparable ownership Top 5
ArrowMark Colorado Holdings LLC 14%
FRANKLIN RESOURCES INC 4.7%
BVF INC/IL 3.8%
FRED ALGER MANAGEMENT, LLC 2.3%
CITADEL ADVISORS LLC 1.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ArrowMark Colorado Holdings LLC
13F
Company
13F
14%
$142,460,000
2,936,708 shares
30 Sep 2020
FRANKLIN RESOURCES INC
13F
Company
13F
4.7%
$46,999,000
968,858 shares
30 Sep 2020
BVF INC/IL
13F
Company
13F
3.8%
$37,719,000
777,553 shares
30 Sep 2020
FRED ALGER MANAGEMENT, LLC
13F
Company
13F
2.3%
$22,598,000
465,832 shares
30 Sep 2020
CITADEL ADVISORS LLC
13F
Company
13F
1.7%
$16,523,000
340,622 shares
30 Sep 2020
ORBIMED ADVISORS LLC
13F
Company
13F
1.7%
$16,517,000
340,480 shares
30 Sep 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
49
Shares
8,392,546
Rows available
49
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
45
Q4 2020 holders
49
Holder diff
4
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 value Q4 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .